Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Golgin subfamily A member 6-like protein 25 (GOLGA6L25) is classified in human genomic databases as a pseudogene related to the golgin family of Golgi-localized coiled-coil proteins. Unlike bona fide golgin proteins, such as GM130, Golgin-45, GRASP55, and GRASP65, which are well-characterized as critical components for Golgi structural maintenance, stacking, and vesicle tethering[1][3][5], GOLGA6L25 does not encode a functional protein and is not involved in any known cellular pathway, drug interaction, or disease mechanism[4]. It does not have validated protein expression in human tissues and lacks any known involvement in signal transduction, cell cycle, cell death, or immune response. If you require information on functional members of the golgin protein family involved in Golgi apparatus structure (e.g. GRASP65, GM130, Golgin-45), those are well-defined and play roles in organelle architecture, vesicle trafficking, and are being studied for disease associations[1][3][5]. However, GOLGA6L25 is not among these and should not be considered a validated drug or receptor target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Golgin subfamily A member 6-like protein 25 (GOLGA6L25).